Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first studyJiang Ming Fam, Roberto Diletti, Marco Valgimigli et al.|EuroIntervention|2016Cited by 21
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusionsJiang Ming Fam, Roberto Diletti, Soledad Ojeda et al.|EuroIntervention|2017Cited by 16
Differential thrombotic prolapse burden in either bioresorbable vascular scaffolds or metallic stents implanted during acute myocardial infarctionRoberto Diletti, Robert‐Jan van Geuns, Jors van der Sijde et al.|International Journal of Cardiology|2016Cited by 10
Late and very late scaffold thrombosisΑντώνιος Καρανάσος, Bu‐Chun Zhang, Jors van der Sijde et al.|Unknown|2017Cited by 0
OCT is the way to goJiang Ming Fam, Evelyn Regar, Nienke S. van Ditzhuijzen et al.|Unknown|2017Cited by 0